Covid-19 epidemiology in Latin America

• Autores: Calzada-Gonzales, Nancy, Calzada-Gonzales, Maribel
• Formato: artículo
• Fecha de Publicación: 2020
• Institución: Universidad de Huánuco
• Repositorio: Revista UDH - Revista Peruana de Ciencias de la Salud
• Lenguaje: español
• OAI Identifier: oai:ojs.revistas.udh.edu.pe:article/126
• Enlace del recurso: http://revistas.udh.edu.pe/index.php/RPCS/article/view/126
• Nivel de acceso: acceso abierto
• Materia: de edad mediana; síndrome respiratorio agudo severo; COVID-19; coronavirus; cuarentena; enzima convertidora de angiotensina 2; Peptidil-dipeptidasa A.; America latina; salud pública; cuerpo humano; infecciones por coronavirus; China; brotes de enfermedades; neumonía

Severe acute respiratory syndrome (SARS), is caused by coronavirus (SARSCoV-2). It uses the angiotensin-converting enzyme 2 receptor (ACE2) to invade human bodies. In December 2019, an unprecedented outbreak of pneumonia of unknown etiology emerged in Wuhan City, Hubei Province of China. The outbreak was reported to the WHO on December 31, 2019, who on February 11 named it COVID-19. Latin America was no exception to thispublic health problem. On February 25, 2020, the Brazilian Department of Health confrmed the frst confrmed case of a 61-year-old Brazilian man. Currently, despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 3,435,894 laboratory confrmed cases and more than 239,000 deaths worldwide. In response to this global outbreak, we will conduct an epidemiology review regarding Latin American.